M. Averbuch et M. Katzper, Baseline pain and response to analgesic medications in the postsurgery dental pain model, J CLIN PHAR, 40(2), 2000, pp. 133-137
In designing clinical trials for the treatment of acute pain, enrollment of
patients with moderate to severe pain is recommended even when the desired
indication is treatment of mild pain. To test this approach, the authors e
xplored the results of two studies that had the same standard placebo-contr
olled, parallel-group design and that compared the study medication to a si
ngle dose of ibuprofen 400 mg. One study had 25 subjects, the other 50 in i
ts ibuprofen arm. Subjects indicating moderate or severe pain (on a scale r
anging from 0 = none, 1 = mild, 2 = moderate, 3 = severe) following a surgi
cal extraction of two or more third molars were enrolled. There was a diffe
rence between the ibuprofen groups in these two studies in average baseline
pain intensity (PI) (2.88 +/- 0.33 vs. 2.26 +/- 0.44). In the higher basel
ine group, PI decreased faster, achieving lower levels of PI that were main
tained for the rest of the study period. The results of pain relief measure
ments paralleled those of PI. The authors conclude that including patients
with a higher degree of baseline pain in the postoperative dental pain mode
l has the potential to increase discrimination of analgesic properties of n
ew drugs. Journal of Clinical Pharmacology, 2000;40:133-137 (C)2000 the Ame
rican College of Clinical Pharmacology.